Trends in the proportion of patients with lung cancer meeting screening criteria

doi:10.1001/jama.2015.413

. 2015 Feb 24;313(8):853-5.

doi: 10.1001/jama.2015.413.

Trends in the proportion of patients with lung cancer meeting screening criteria

Yi Wang¹, David E Midthun², Jason A Wampfler³, Bo Deng⁴, Shawn M Stoddard⁴, Shuo Zhang⁴, Ping Yang⁴

Affiliations

¹ Division of Epidemiology, Mayo Clinic, Rochester, Minnesota4Dr Wang is now with the Division of Preventive Medicine, Wenzhou Medical University, Wenzhou, China.
² Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.
³ Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
⁴ Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.

PMID: 25710663
PMCID: PMC4493881
DOI: 10.1001/jama.2015.413

Trends in the proportion of patients with lung cancer meeting screening criteria

Yi Wang et al. JAMA. 2015.

. 2015 Feb 24;313(8):853-5.

doi: 10.1001/jama.2015.413.

Authors

Yi Wang¹, David E Midthun², Jason A Wampfler³, Bo Deng⁴, Shawn M Stoddard⁴, Shuo Zhang⁴, Ping Yang⁴

Affiliations

¹ Division of Epidemiology, Mayo Clinic, Rochester, Minnesota4Dr Wang is now with the Division of Preventive Medicine, Wenzhou Medical University, Wenzhou, China.
² Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.
³ Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
⁴ Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.

PMID: 25710663
PMCID: PMC4493881
DOI: 10.1001/jama.2015.413

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Figures

**Figure**
Temporal Pattern of Coverage Proportion by USPSTF Screening Criteria in Olmsted County (Minnesota), 1984–2011 A. Overall B. Stratified by Sex

See this image and copyright information in PMC

Cited by

Comparison of lung cancer occurring in fibrotic versus non-fibrotic lung on chest CT.
Salvatore MM, Liu Y, Peng B, Hsu HY, Saqi A, Tsai WY, Leu CS, Jambawalikar S. Salvatore MM, et al. J Transl Med. 2024 Jan 16;22(1):67. doi: 10.1186/s12967-023-04645-y. J Transl Med. 2024. PMID: 38229113 Free PMC article.
TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk.
Craig DJ, Crawford EL, Chen H, Grogan EL, Deppen SA, Morrison T, Antic SL, Massion PP, Willey JC. Craig DJ, et al. BMC Cancer. 2023 Aug 23;23(1):783. doi: 10.1186/s12885-023-11266-7. BMC Cancer. 2023. PMID: 37612638 Free PMC article.
Stratification of Risk Factors of Lung Cancer-Associated Venous Thromboembolism and Determining the Critical Point for Preemptive Intervention: A Systematic Review With Meta-analysis.
Nwagha T, Nweke M. Nwagha T, et al. Clin Med Insights Oncol. 2023 Jun 28;17:11795549231175221. doi: 10.1177/11795549231175221. eCollection 2023. Clin Med Insights Oncol. 2023. PMID: 37426681 Free PMC article. Review.
Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer.
Forder A, Zhuang R, Souza VGP, Brockley LJ, Pewarchuk ME, Telkar N, Stewart GL, Benard K, Marshall EA, Reis PP, Lam WL. Forder A, et al. Int J Mol Sci. 2023 Feb 2;24(3):2859. doi: 10.3390/ijms24032859. Int J Mol Sci. 2023. PMID: 36769181 Free PMC article. Review.
Machine Learning and Real-World Data to Predict Lung Cancer Risk in Routine Care.
Chandran U, Reps J, Yang R, Vachani A, Maldonado F, Kalsekar I. Chandran U, et al. Cancer Epidemiol Biomarkers Prev. 2023 Mar 6;32(3):337-343. doi: 10.1158/1055-9965.EPI-22-0873. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36576991 Free PMC article.

See all "Cited by" articles

References

1. Moyer VA U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330–338. - PubMed
1. St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ, 3rd, Rocca WA. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc. 2012;87(2):151–160. - PMC - PubMed
1. McCullagh P, Nelder JA. Generalized Linear Models. London: Chapman and Hall; 1983.
1. Bergstralh EJ, Offord KP, Chu CP, Beard CM, O’Fallon WM, Melton LJ., 3rd . Technical Report Series No. 49. Department of Health Science Research, Mayo Clinic; Rochester, Minnesota: Apr, 1992. Calculating Incidence, Prevalence, and Mortality Rates for Olmsted County, Minnesota: An Update.
1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- H1 Connect
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Moyer VA U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330–338. - PubMed

[2] Moyer VA U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330–338. - PubMed

[3] St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ, 3rd, Rocca WA. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc. 2012;87(2):151–160. - PMC - PubMed

[4] St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ, 3rd, Rocca WA. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc. 2012;87(2):151–160. - PMC - PubMed

[5] McCullagh P, Nelder JA. Generalized Linear Models. London: Chapman and Hall; 1983.

[6] McCullagh P, Nelder JA. Generalized Linear Models. London: Chapman and Hall; 1983.

[7] Bergstralh EJ, Offord KP, Chu CP, Beard CM, O’Fallon WM, Melton LJ., 3rd . Technical Report Series No. 49. Department of Health Science Research, Mayo Clinic; Rochester, Minnesota: Apr, 1992. Calculating Incidence, Prevalence, and Mortality Rates for Olmsted County, Minnesota: An Update.

[8] Bergstralh EJ, Offord KP, Chu CP, Beard CM, O’Fallon WM, Melton LJ., 3rd . Technical Report Series No. 49. Department of Health Science Research, Mayo Clinic; Rochester, Minnesota: Apr, 1992. Calculating Incidence, Prevalence, and Mortality Rates for Olmsted County, Minnesota: An Update.

[9] Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. - PubMed

[10] Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Trends in the proportion of patients with lung cancer meeting screening criteria

Affiliations

Trends in the proportion of patients with lung cancer meeting screening criteria

Authors

Affiliations

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical